SOURCE: CrownPeak

May 06, 2008 10:00 ET

CrownPeak Helps Pharmaceutical/Biotech Client CV Therapeutics Manage and Distribute Content

LOS ANGELES, CA--(Marketwire - May 6, 2008) - CrownPeak, the company defining the future of content management, today announced that CV Therapeutics, Inc. has implemented CrownPeak's award-winning content management system (CMS) to manage three of the company's Web sites. CV Therapeutics, a biopharmaceutical company primarily focused on the discovery, development and commercialization of new small molecule drugs for the treatment of cardiovascular diseases, represents CrownPeak's first client in the pharmaceutical or biotech industry.

The CrownPeak CMS has enabled internal stakeholders at CV Therapeutics to update general company, R&D, investor and career information on the corporate Web site www.cvt.com. The CMS is also being utilized to manage information on www.Ranexa.com for the company's premier product Ranexa® (ranolazine extended-release tablets), the first new pharmaceutical approach to treat chronic angina in the United States in more than 20 years.

"Being able to communicate accurate information with our various stakeholders in a timely fashion is absolutely critical in our industry," says Tina Sampath, Associate Director of eMarketing for CV Therapeutics. "Prior to implementing the CrownPeak CMS, we were completely reliant upon a third party web agency. Now with CrownPeak, we have complete control of the update process for our Web sites."

In addition to implementing the actual content management system, CrownPeak manages web hosting and web analytics for CV Therapeutics.

"With the understanding that timely dissemination of accurate information is very importance in their field, our aim was to tailor the control of each Web site to match the goal of their particular audience," says Jim Howard, chief executive officer of CrownPeak. "We are honored that a distinguished pharmaceutical firm such as CV Therapeutics would entrust the entire management of their content systems to us. We look forward to building out new features that will continue to make it easier for CV Therapeutics to communicate with their various audiences."

About CrownPeak

CrownPeak is the market leader in providing on-demand Web site software. CrownPeak's unique combination of software and services give Web site managers complete control over the critical functions involved in delivering a successful, revenue-driving Web site.

Hundreds of diverse organizations such as 3M, Hyundai Motors, Home Depot, EMI Music, the State of Virginia and the National Institutes of Health have realized the value in CrownPeak's software's renowned ease-of-use, and its 24x7 customer support and guaranteed response times. CrownPeak's ContentManagement.com also provides easy to use and cost-effective content management solutions for smaller and mid-sized organizations. CrownPeak has been named to EContent's 100 most influential companies list, has won eWeek's prestigious Analysts Choice Award and InfoWorld's Product of the Year Award and has been named a finalist for Best Customer Service from the American Business "Stevie" Awards for the last two years.

About CV Therapeutics

CV Therapeutics, Inc., headquartered in Palo Alto, California, is a biopharmaceutical company primarily focused on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases.

CV Therapeutics' approved products include Ranexa® (ranolazine extended-release tablets), indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs, and Lexiscan™ (regadenoson) injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress.

Contact Information